Sign in

NCT06765421Not yet recruiting

Optimising General Practice Long COVID Care - an Educational Intervention.

Optimising General Practice Long COVID Care - Feasibility Trial of a Pilot Educational Intervention.

Source: ClinicalTrials.gov · Last updated 9 Jan 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

This trial will evaluate the feasibility of a pilot educational intervention for GPs that aims to enhance care and care outcomes among patients with long COVID at six general practices in the Ireland East region. Our first objective is to conduct focus groups with key stakeholders (GPs, other health professionals, patients, families/carers) that will inform the contents of an education intervention. The second objective will be to implement this educational intervention, and the third objective will be to determine whether the intervention is feasible. Study outcomes will include: * Qualitative findings from co-design focus groups and post-intervention semi-structured interviews with GPs. * Practice and patient study recruitment and retention data. * GP / Practice characteristics: age \& gender, practice location, general and COVID-19 patient population figures. * Patient characteristics: Patient age, gender, COVID-19 vaccination status, and medical history details. * Patient scores on a self-report measure assessing the symptoms, symptom severity, functional impact, and overall health (COVID-19 Yorkshire Rehabilitation Scale (C-19-YRS)).

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
72 (estimated)
First submitted
12 Dec 2024
Start date
Mar 2025
Primary completion date
Apr 2025
Lead sponsor
University College Dublin
NCT number
NCT06765421

What you commit to

  • Study type: Interventional
  • Planned participants: 72
  • From Mar 2025 to the primary completion date, Apr 2025
  • No sites listed in no country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Individuals with a recognised or diagnosed intellectual, physical, or mental impairment.

Other

  • 1\. Vulnerability: Deemed by participating GPs to be a vulnerable individual whose best interests are served by not participating in the study, such as (but not limited to):
  • People with language difficulties that prevent meaningful communication.
  • Older adults considered particularly vulnerable.
  • Individuals residing in institutions (e.g., care homes or prisons).
  • Individuals with an unequal relationship with the researcher(s) (e.g., hierarchical dependence).
  • Members of marginalised or disadvantaged groups for whom participation may present undue burden or risk.

Who the study is looking for

  • Age: Aged 18 years or older at the time of enrolment.
  • Registration: Are registered as patients at the study's participating practices.
  • COVID-19 Diagnosis:
    • Previously received a positive COVID-19 PCR or antigen test, or
    • Previously been clinically diagnosed with COVID-19 by a healthcare provider.
  • Persistent Symptoms:
    • o Have spoken with their general practitioner (GP) about experiencing persistent symptoms lasting four weeks or more since their COVID-19 diagnosis.
  • Consent: Willing and able to provide informed consent to participate in the study.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

This page is information, not medical advice. Discuss any trial with your doctor.